Mclean Hospital

Clinicians Embracing New Depression Drug Esketamine With ‘Enthusiastic Caution’

March 6, 2019

STAT

Dr. Robert Meisner offers feedback on the FDA’s approval of a new ketamine product.

Read Full Article

Topics

Depression Ketamine Robert Meisner

Related Content

Increased Volume and New Services Spur Change in McLean’s Psychiatric Neurotherapeutics Program

ECT Gave Me My Life Back

ECT Pioneer and Mental Health Advocate Charles Welch, MD, Retires From McLean

Algorithm Identifies Patients Best Suited for Antidepressants
tags%5B%5D=811&tags%5B%5D=3816

More

Resources

In the Media
Media Contact
News
Experts

Latest Videos

2 boys holding pipe cleaners shaped like neurons

McLean in Mumbai: Educating Clinicians and the Public About Mental Health

Rocco A. Iannucci, MD

Dr. Rocco Iannucci on the Impact of Addiction Recovery

Shelly F. Greenfield, MD, MPH

McLean Doctors Read Stories of Mental Health Recovery

Treatment at McLean

Gunderson BPD Programs: Treatment for Adults with Personality Disorders

More
Videos